Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
305 studies found for:    Open Studies | "Kidney Neoplasms"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting The Pharmacokinetic Variability of Sunitinib in Patients With Metastatic Renal Cancer
Condition: Kidney Neoplasms
Interventions: Genetic: Blood drawn for genotyping;   Biological: Blood drawn for pharmacokinetic measures
2 Recruiting Irreversible Electroporation(IRE) For Unresectable Renal Tumors
Condition: Renal Tumor
Intervention: Procedure: irreversible electroporation
3 Recruiting Stereotactic Radiotherapy for Renal Cancers
Condition: Renal Cancer
Interventions: Radiation: Stereotactic radiotherapy 4 x 8 Gy;   Radiation: Stereotactic radiotherapy 5 x 8 Gy;   Radiation: Stereotactic radiotherapy 4 x 10 Gy;   Radiation: Stereotactic radiotherapy 4 x 12 Gy
4 Recruiting Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer
Condition: Renal Cancers
Intervention: Radiation: Stereotactic Ablative Radiation Therapy
5 Recruiting Kidney Cancer DNA Registry
Condition: Renal Cancer
Interventions: Other: salvia for germline DNA;   Behavioral: the Kidney Cancer Questionnaire;   Behavioral: Family History Questionnaire (when applicable)
6 Recruiting Perfusion Scanning's for Kidney Tumors
Condition: Kidney Cancer
Intervention:
7 Recruiting Prospective Randomized Study Comparing Laparoscopic Versus Open Partial Nephrectomy
Condition: Kidney Neoplasms
Intervention: Procedure: Partial nephrectomy
8 Recruiting Radiosurgery in Treating Patients With Kidney Tumors
Condition: Kidney Cancer
Interventions: Radiation: stereotactic radiosurgery;   Procedure: Renal Biopsy;   Procedure: Serum Blood Markers
9 Not yet recruiting Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: Pembrolizumab;   Drug: Interleukin-2
10 Not yet recruiting Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial
Conditions: Renal Cell Carcinoma;   Kidney Cancer
Interventions: Drug: Sunitinib;   Drug: Isoquercetin;   Drug: Placebo
11 Recruiting The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry
Condition: Kidney Neoplasm
Intervention:
12 Recruiting Assessment of Oncological and Functional Outcomes After Robot Assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy
Condition: Kidney Neoplasms
Interventions: Procedure: Laparoscopic partial nephrectomy;   Procedure: Robot assisted partial nephrectomy;   Device: Conventional laparoscopic instruments;   Device: Da- Vinci Robot and conventional laparoscopic instruments;   Drug: Mannitol
13 Recruiting Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 Stage
Condition: Kidney Neoplasms
Interventions: Procedure: conventional laparoscopic partial nephrectomy;   Procedure: zero ischemia laparoscopic RFA/MVA assisted tumor enucleation (TE)
14 Recruiting Thermal Ablation in Larger Liver and Kidney Tumours
Condition: Liver and Kidney Tumours
Intervention: Device: RFA Loosely wound thermal coil
15 Recruiting Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Conditions: Renal Tumor Histology;   Cutaneous Leiomyomatosis;   Kidney Cancer
Intervention:
16 Recruiting Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
Condition: Kidney Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: sunitinib malate
17 Recruiting Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Conditions: Kidney Neoplasms;   Kidney Cancer;   Pneumothorax;   FLCN Protien, Human
Intervention:
18 Not yet recruiting A Study Combining NeoVax, a Personalized NeoAntigen Cancer Vaccine, With Ipilimumab to Treat High-risk Renal Cell Carcinoma
Condition: Kidney Cancer
Interventions: Drug: NeoVax;   Drug: Ipilimumab
19 Recruiting Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
Conditions: Renal Cancer;   Chromophobe Renal Cell Carcinoma;   Birt-Hogg-Dube Syndrome
Intervention: Drug: Everolimus
20 Recruiting Off Clamp Randomization
Conditions: Renal Cancer;   Renal Ischemia
Intervention: Procedure: Off-clamp partial nephrectomy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.